The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B


Creative Commons License

Ciftciler R., Ozenirler S., Yucel A. A. , Cengiz M., Erkan G., Buyukdemirci E., ...Daha Fazla

JOURNAL OF CLINICAL LABORATORY ANALYSIS, cilt.31, sa.5, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Konu: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1002/jcla.22109
  • Dergi Adı: JOURNAL OF CLINICAL LABORATORY ANALYSIS

Özet

BackgroundLiver biopsy is recommended in the majority of patients with chronic viral hepatitis for fibrosis evaluation. Because of the potential risks of liver biopsy, many studies related to non-invasive biomarkers of hepatic fibrosis have been performed. We aimed to assess the diagnostic value of serum biglycan as a non-invasive fibrosis marker in chronic hepatitis B patients.